JP2018196385A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018196385A5 JP2018196385A5 JP2018145578A JP2018145578A JP2018196385A5 JP 2018196385 A5 JP2018196385 A5 JP 2018196385A5 JP 2018145578 A JP2018145578 A JP 2018145578A JP 2018145578 A JP2018145578 A JP 2018145578A JP 2018196385 A5 JP2018196385 A5 JP 2018196385A5
- Authority
- JP
- Japan
- Prior art keywords
- birc5
- normalized
- ube2c
- breast cancer
- level
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000000763 Survivin Human genes 0.000 claims 39
- 108010002687 Survivin Proteins 0.000 claims 39
- 101000807354 Homo sapiens Ubiquitin-conjugating enzyme E2 C Proteins 0.000 claims 38
- 102100037256 Ubiquitin-conjugating enzyme E2 C Human genes 0.000 claims 38
- 238000000034 method Methods 0.000 claims 25
- 206010006187 Breast cancer Diseases 0.000 claims 23
- 208000026310 Breast neoplasm Diseases 0.000 claims 23
- 108091093088 Amplicon Proteins 0.000 claims 21
- 101000599056 Homo sapiens Interleukin-6 receptor subunit beta Proteins 0.000 claims 19
- 102100037795 Interleukin-6 receptor subunit beta Human genes 0.000 claims 19
- 238000004393 prognosis Methods 0.000 claims 13
- 206010027476 Metastases Diseases 0.000 claims 7
- 230000009401 metastasis Effects 0.000 claims 7
- 239000002299 complementary DNA Substances 0.000 claims 5
- 238000004590 computer program Methods 0.000 claims 5
- 230000004083 survival effect Effects 0.000 claims 5
- 102000015694 estrogen receptors Human genes 0.000 claims 4
- 108010038795 estrogen receptors Proteins 0.000 claims 4
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 238000010839 reverse transcription Methods 0.000 claims 2
- 238000001574 biopsy Methods 0.000 claims 1
- 238000010606 normalization Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26376309P | 2009-11-23 | 2009-11-23 | |
| US61/263,763 | 2009-11-23 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016129697A Division JP2016214245A (ja) | 2009-11-23 | 2016-06-30 | 癌の臨床転帰を予測する方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020218527A Division JP2021058207A (ja) | 2009-11-23 | 2020-12-28 | 癌の臨床転帰を予測する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018196385A JP2018196385A (ja) | 2018-12-13 |
| JP2018196385A5 true JP2018196385A5 (cg-RX-API-DMAC7.html) | 2019-02-28 |
| JP7042717B2 JP7042717B2 (ja) | 2022-03-28 |
Family
ID=44060376
Family Applications (7)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012540103A Active JP5964752B2 (ja) | 2009-11-23 | 2010-11-19 | 癌の臨床転帰を予測する方法 |
| JP2016129697A Pending JP2016214245A (ja) | 2009-11-23 | 2016-06-30 | 癌の臨床転帰を予測する方法 |
| JP2018145578A Active JP7042717B2 (ja) | 2009-11-23 | 2018-08-02 | 癌の臨床転帰を予測する方法 |
| JP2020218527A Pending JP2021058207A (ja) | 2009-11-23 | 2020-12-28 | 癌の臨床転帰を予測する方法 |
| JP2022123265A Pending JP2022166064A (ja) | 2009-11-23 | 2022-08-02 | 癌の臨床転帰を予測する方法 |
| JP2022129605A Pending JP2022169647A (ja) | 2009-11-23 | 2022-08-16 | 癌の臨床転帰を予測する方法 |
| JP2023213416A Pending JP2024037948A (ja) | 2009-11-23 | 2023-12-18 | 癌の臨床転帰を予測する方法 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012540103A Active JP5964752B2 (ja) | 2009-11-23 | 2010-11-19 | 癌の臨床転帰を予測する方法 |
| JP2016129697A Pending JP2016214245A (ja) | 2009-11-23 | 2016-06-30 | 癌の臨床転帰を予測する方法 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020218527A Pending JP2021058207A (ja) | 2009-11-23 | 2020-12-28 | 癌の臨床転帰を予測する方法 |
| JP2022123265A Pending JP2022166064A (ja) | 2009-11-23 | 2022-08-02 | 癌の臨床転帰を予測する方法 |
| JP2022129605A Pending JP2022169647A (ja) | 2009-11-23 | 2022-08-16 | 癌の臨床転帰を予測する方法 |
| JP2023213416A Pending JP2024037948A (ja) | 2009-11-23 | 2023-12-18 | 癌の臨床転帰を予測する方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US20110123990A1 (cg-RX-API-DMAC7.html) |
| EP (4) | EP4350001A3 (cg-RX-API-DMAC7.html) |
| JP (7) | JP5964752B2 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2010321829B2 (cg-RX-API-DMAC7.html) |
| CA (2) | CA3043089A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK2504451T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2735993T3 (cg-RX-API-DMAC7.html) |
| HU (1) | HUE044374T2 (cg-RX-API-DMAC7.html) |
| IL (5) | IL219051A (cg-RX-API-DMAC7.html) |
| MX (3) | MX391499B (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ599194A (cg-RX-API-DMAC7.html) |
| PL (1) | PL2504451T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011063274A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040231909A1 (en) | 2003-01-15 | 2004-11-25 | Tai-Yang Luh | Motorized vehicle having forward and backward differential structure |
| EP1737980A2 (en) | 2004-04-09 | 2007-01-03 | Fondazione IRCCS Istituto Nazionale dei Tumori | Gene expression markers for predicting response to chemotherapy |
| DK1836629T3 (da) * | 2004-11-05 | 2020-05-18 | Genomic Health Inc | Forudsigelse af respons på kemoterapi ved anvendelse af markører for genekspression |
| WO2007123772A2 (en) | 2006-03-31 | 2007-11-01 | Genomic Health, Inc. | Genes involved in estrogen metabolism |
| AU2009262022A1 (en) * | 2008-06-26 | 2009-12-30 | Dana-Farber Cancer Institute, Inc. | Signatures and determinants associated with metastasis and methods of use thereof |
| US20120041274A1 (en) | 2010-01-07 | 2012-02-16 | Myriad Genetics, Incorporated | Cancer biomarkers |
| DK177532B1 (en) | 2009-09-17 | 2013-09-08 | Bio Bedst Aps | Medical use of sPLA2 hydrolysable liposomes |
| US20110123990A1 (en) * | 2009-11-23 | 2011-05-26 | Baker Joffre B | Methods To Predict Clinical Outcome Of Cancer |
| WO2011085263A2 (en) | 2010-01-11 | 2011-07-14 | Genomic Health, Inc. | Method to use gene expression to determine likelihood of clinical outcome of renal cancer |
| GB201009798D0 (en) | 2010-06-11 | 2010-07-21 | Immunovia Ab | Method,array and use thereof |
| CA2804391A1 (en) | 2010-07-07 | 2012-01-12 | Myriad Genetics, Inc. | Gene signatures for cancer prognosis |
| IL243203A (en) | 2010-07-27 | 2017-04-30 | Genomic Health Inc | Method for using gene expression to determine prognosis of prostate cancer |
| WO2012030840A2 (en) | 2010-08-30 | 2012-03-08 | Myriad Genetics, Inc. | Gene signatures for cancer diagnosis and prognosis |
| US8361720B2 (en) | 2010-11-15 | 2013-01-29 | Exact Sciences Corporation | Real time cleavage assay |
| US8916344B2 (en) | 2010-11-15 | 2014-12-23 | Exact Sciences Corporation | Methylation assay |
| US20140113297A1 (en) * | 2011-03-26 | 2014-04-24 | Oregon Health & Science University | Gene expression predictors of cancer prognosis |
| HK1197276A1 (en) * | 2011-06-22 | 2015-01-09 | Oncocyte Corporation | Methods and compositions for the treatment and diagnosis of bladder cancer |
| US20140302042A1 (en) * | 2011-07-01 | 2014-10-09 | Dana-Farber Cancer Institute, Inc. | Methods of predicting prognosis in cancer |
| MX341922B (es) | 2011-07-13 | 2016-09-07 | The Multiple Myeloma Res Found Inc | Metodos de captacion y distribucion de datos. |
| US20140235486A1 (en) * | 2011-08-16 | 2014-08-21 | Oncocyte Corporation | Methods and Compositions for the Treatment and Diagnosis of Breast Cancer |
| WO2013070521A1 (en) * | 2011-11-08 | 2013-05-16 | Genomic Health, Inc. | Method of predicting breast cancer prognosis |
| JP5805518B2 (ja) | 2011-12-21 | 2015-11-04 | 株式会社島津製作所 | マルチプレックス大腸がんマーカーパネル |
| HK1201881A1 (en) | 2012-01-31 | 2015-09-11 | Genomic Health, Inc. | Gene expression profile algorithm and test for determining prognosis of prostate cancer |
| GB201206323D0 (en) * | 2012-04-10 | 2012-05-23 | Immunovia Ab | Methods and arrays for use in the same |
| CN104662166A (zh) * | 2012-04-20 | 2015-05-27 | 纪念斯隆-凯特琳癌症中心 | 与转移性乳腺癌相关的基因表达图谱 |
| US20150299799A1 (en) | 2012-10-05 | 2015-10-22 | Michael Sturzl | Method for Detecting an Increased Risk or Incidence of Colorectal Cancer |
| ES2938766T3 (es) | 2012-11-16 | 2023-04-14 | Myriad Genetics Inc | Firmas génicas para el pronóstico de cáncer |
| KR101672531B1 (ko) * | 2013-04-18 | 2016-11-17 | 주식회사 젠큐릭스 | 조기 유방암 예후 예측 진단용 유전자 마커 및 이의 용도 |
| SG11201506987VA (en) * | 2013-05-30 | 2015-10-29 | Genomic Health Inc | Gene expression profile algorithm for calculating a recurrence score for a patient with kidney cancer |
| WO2014195032A1 (en) * | 2013-06-07 | 2014-12-11 | Medical Prognosis Institute A/S | Methods and devices for predicting treatment efficacy of fulvestrant in cancer patients |
| WO2015138769A1 (en) * | 2014-03-12 | 2015-09-17 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for assessing patients with non-small cell lung cancer |
| CA2947624A1 (en) | 2014-05-13 | 2015-11-19 | Myriad Genetics, Inc. | Gene signatures for cancer prognosis |
| US10184154B2 (en) | 2014-09-26 | 2019-01-22 | Mayo Foundation For Medical Education And Research | Detecting cholangiocarcinoma |
| DK3198035T3 (da) | 2014-09-26 | 2023-01-30 | Allarity Therapeutics Europe ApS | Fremgangsmåder til forudsigelse af medicinrespons |
| WO2016092299A1 (en) * | 2014-12-09 | 2016-06-16 | Medical Research Council | Methods and kits for predicting the response to therapy of cancer |
| EP3274440A4 (en) | 2015-03-27 | 2019-03-06 | Exact Sciences Corporation | Detecting esophageal disorders |
| US10704081B2 (en) | 2015-10-30 | 2020-07-07 | Exact Sciences Development Company, Llc | Multiplex amplification detection assay |
| CA3008273A1 (en) | 2015-12-18 | 2017-06-22 | Clear Gene, Inc. | Methods, compositions, kits and devices for rapid analysis of biological markers |
| US11680298B2 (en) | 2016-09-07 | 2023-06-20 | Agency For Science, Technology And Research | Method of identifying risk of cancer and therapeutic options |
| US9725769B1 (en) | 2016-10-07 | 2017-08-08 | Oncology Venture ApS | Methods for predicting drug responsiveness in cancer patients |
| AU2017258901A1 (en) | 2016-12-30 | 2018-07-19 | Allarity Therapeutics Europe ApS | Methods for predicting drug responsiveness in cancer patients |
| EP3574110A4 (en) | 2017-01-27 | 2021-01-13 | Exact Sciences Development Company, LLC | DETECTION OF COLUMN NEOPLASIA BY ANALYSIS OF METHYLATED DNA |
| WO2018212192A1 (ja) * | 2017-05-18 | 2018-11-22 | 京都府公立大学法人 | 癌の予後及び／又は転移可能性を評価する方法及びマーカー |
| US12275994B2 (en) * | 2017-06-22 | 2025-04-15 | Clear Gene, Inc. | Methods and compositions for the analysis of cancer biomarkers |
| KR102424222B1 (ko) | 2017-11-13 | 2022-07-21 | 더 멀티플 마이얼로머 리서치 파운데이션, 인크. | 통합된, 분자, 체학, 면역요법, 대사, 후성적, 및 임상 데이터베이스 |
| US10648025B2 (en) | 2017-12-13 | 2020-05-12 | Exact Sciences Development Company, Llc | Multiplex amplification detection assay II |
| US11549152B2 (en) * | 2018-03-08 | 2023-01-10 | University Of Notre Dame Du Lac | Products for assessing colorectal cancer molecular subtype and risk of recurrence and for determining and administering treatment protocols based thereon |
| JP7199045B2 (ja) * | 2018-04-13 | 2023-01-05 | 国立大学法人大阪大学 | 乳癌の予後に関する情報の取得方法、乳癌の予後の判定装置及びコンピュータプログラム |
| US20220120753A1 (en) * | 2018-09-21 | 2022-04-21 | The University Of Tokyo | Method for determining prognosis of cancer |
| JP2019032334A (ja) * | 2018-10-03 | 2019-02-28 | イムノヴィア・アクチエボラーグ | 乳癌関連の疾患状態を決定する方法およびこの方法における使用のためのアレイ |
| KR102216645B1 (ko) * | 2018-10-29 | 2021-02-17 | 사회복지법인 삼성생명공익재단 | 폐암의 분자 아형 결정을 위한 바이오마커 패널 및 이의 용도 |
| SG11202106130UA (en) * | 2018-12-08 | 2021-07-29 | Pfs Genomics Inc | Transcriptomic profiling for prognosis of breast cancer |
| CN113785076B (zh) * | 2019-05-03 | 2024-06-11 | 株式会社递希真 | 预测癌症预后的方法及其组合物 |
| CN111235270B (zh) * | 2019-08-29 | 2022-04-29 | 北京臻知医学科技有限责任公司 | 一种基于高通量测序法的肿瘤抗原表达检测引物及试剂盒 |
| US12165747B2 (en) * | 2020-01-23 | 2024-12-10 | The Broad Institute, Inc. | Molecular spatial mapping of metastatic tumor microenvironment |
| EP4291676A4 (en) * | 2021-02-12 | 2025-05-07 | Mammogen, Inc. | Biomarkers for the diagnosis of breast cancer |
| WO2022192128A2 (en) * | 2021-03-08 | 2022-09-15 | Castle Biosciences, Inc. | Determining prognosis and treatment based on clinical-pathologic factors and continuous multigene-expression profile scores |
| CN117116345B (zh) * | 2023-07-24 | 2025-09-16 | 中国人民解放军军事科学院军事医学研究院 | 一种基于基因调控网络构建患者生存网络的方法 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005500832A (ja) * | 2001-06-18 | 2005-01-13 | ロゼッタ・インファーマティクス・インコーポレーテッド | 乳癌患者の診断および予後 |
| US7171311B2 (en) * | 2001-06-18 | 2007-01-30 | Rosetta Inpharmatics Llc | Methods of assigning treatment to breast cancer patients |
| AU2002322280A1 (en) * | 2001-06-21 | 2003-01-21 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| DK1918386T3 (da) * | 2002-03-13 | 2012-01-02 | Genomic Health Inc | Genekspressionsprofiler i biopsier af tumorvæv |
| US20040067234A1 (en) * | 2002-07-11 | 2004-04-08 | Paz Einat | Isocitrate dehydrogenase and uses thereof |
| US20040231909A1 (en) * | 2003-01-15 | 2004-11-25 | Tai-Yang Luh | Motorized vehicle having forward and backward differential structure |
| DK1644858T3 (da) * | 2003-07-10 | 2018-01-22 | Genomic Health Inc | Funktionel beklædning med mindst et yderlag og en indermembran. |
| CA2558808A1 (en) * | 2004-03-05 | 2005-09-22 | Rosetta Inpharmatics Llc | Classification of breast cancer patients using a combination of clinical criteria and informative genesets |
| JP2008515398A (ja) * | 2004-09-30 | 2008-05-15 | バイエル・ヘルスケア・アクチェンゲゼルシャフト | 癌治療における治療の成功および再発しない生存を予測するための方法およびキット |
| KR20080004551A (ko) * | 2005-04-01 | 2008-01-09 | 엔씨씨 테크놀로지 벤쳐스 피티이 리미티드 | 유방암 분류에 관한 재료 및 방법 |
| WO2006133460A2 (en) * | 2005-06-09 | 2006-12-14 | Yale University | Methods for diagnosing and treating breast cancer based on a her/er ratio |
| WO2006138275A2 (en) * | 2005-06-13 | 2006-12-28 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
| WO2006135886A2 (en) * | 2005-06-13 | 2006-12-21 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
| TWI304443B (en) * | 2005-12-30 | 2008-12-21 | Nat Health Research Institutes | Alpha-enolase specific antibody and method of use |
| WO2007123772A2 (en) * | 2006-03-31 | 2007-11-01 | Genomic Health, Inc. | Genes involved in estrogen metabolism |
| WO2008155661A2 (en) * | 2007-04-16 | 2008-12-24 | Ipsogen | Methods of assessing a propensity of clinical outcome for a female mammal suffering from breast cancer |
| WO2008150512A2 (en) * | 2007-06-04 | 2008-12-11 | University Of Louisville Research Foundation, Inc. | Methods for identifying an increased likelihood of recurrence of breast cancer |
| WO2009095319A1 (en) * | 2008-01-28 | 2009-08-06 | Siemens Healthcare Diagnostics Gmbh | Cancer prognosis by majority voting |
| WO2009132928A2 (en) * | 2008-05-02 | 2009-11-05 | Siemens Healthcare Diagnostics Gmbh | Molecular markers for cancer prognosis |
| EP2568053B1 (en) * | 2008-05-12 | 2014-04-16 | Genomic Health, Inc. | Tests to predict responsiveness of cancer patients to chemotherapy treatment options |
| US20110123990A1 (en) * | 2009-11-23 | 2011-05-26 | Baker Joffre B | Methods To Predict Clinical Outcome Of Cancer |
-
2010
- 2010-11-19 US US12/950,732 patent/US20110123990A1/en not_active Abandoned
- 2010-11-19 HU HUE10832289 patent/HUE044374T2/hu unknown
- 2010-11-19 AU AU2010321829A patent/AU2010321829B2/en active Active
- 2010-11-19 WO PCT/US2010/057490 patent/WO2011063274A2/en not_active Ceased
- 2010-11-19 MX MX2019003811A patent/MX391499B/es unknown
- 2010-11-19 EP EP23213439.5A patent/EP4350001A3/en active Pending
- 2010-11-19 NZ NZ599194A patent/NZ599194A/en unknown
- 2010-11-19 EP EP10832289.2A patent/EP2504451B1/en active Active
- 2010-11-19 JP JP2012540103A patent/JP5964752B2/ja active Active
- 2010-11-19 MX MX2012005822A patent/MX337650B/es active IP Right Grant
- 2010-11-19 EP EP20177718.2A patent/EP3739060A1/en not_active Withdrawn
- 2010-11-19 CA CA3043089A patent/CA3043089A1/en not_active Withdrawn
- 2010-11-19 ES ES10832289T patent/ES2735993T3/es active Active
- 2010-11-19 CA CA2776751A patent/CA2776751C/en active Active
- 2010-11-19 EP EP19175741.8A patent/EP3556867A1/en not_active Withdrawn
- 2010-11-19 DK DK10832289.2T patent/DK2504451T3/da active
- 2010-11-19 PL PL10832289T patent/PL2504451T3/pl unknown
- 2010-11-19 MX MX2016003089A patent/MX363817B/es unknown
-
2012
- 2012-04-04 IL IL219051A patent/IL219051A/en active IP Right Grant
-
2016
- 2016-06-30 JP JP2016129697A patent/JP2016214245A/ja active Pending
- 2016-11-23 IL IL249159A patent/IL249159A0/en unknown
-
2017
- 2017-02-03 US US15/423,977 patent/US20170211154A1/en not_active Abandoned
-
2018
- 2018-01-21 IL IL257063A patent/IL257063B/en active IP Right Grant
- 2018-08-02 JP JP2018145578A patent/JP7042717B2/ja active Active
-
2019
- 2019-01-03 IL IL264072A patent/IL264072B/en active IP Right Grant
- 2019-01-09 US US16/243,207 patent/US20190241967A1/en not_active Abandoned
-
2020
- 2020-08-04 IL IL276487A patent/IL276487B/en unknown
- 2020-09-11 US US17/018,143 patent/US20210062275A1/en not_active Abandoned
- 2020-12-28 JP JP2020218527A patent/JP2021058207A/ja active Pending
-
2022
- 2022-08-02 JP JP2022123265A patent/JP2022166064A/ja active Pending
- 2022-08-16 JP JP2022129605A patent/JP2022169647A/ja active Pending
-
2023
- 2023-12-18 JP JP2023213416A patent/JP2024037948A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018196385A5 (cg-RX-API-DMAC7.html) | ||
| JP2016214245A5 (cg-RX-API-DMAC7.html) | ||
| Cho et al. | Gene expression signature–based prognostic risk score in gastric cancer | |
| Huang et al. | Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer | |
| JP2021177761A5 (cg-RX-API-DMAC7.html) | ||
| JP2020188787A (ja) | 膵臓がんの検出キット又はデバイス及び検出方法 | |
| JP2010538609A5 (cg-RX-API-DMAC7.html) | ||
| JP2016174600A5 (cg-RX-API-DMAC7.html) | ||
| Hua et al. | Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer | |
| CN106148529B (zh) | 与胃癌相关的LncRNA标记物及其专用检测引物、检测方法、试剂盒与应用 | |
| Tokumitsu et al. | A new prognostic model for hepatocellular carcinoma recurrence after curative hepatectomy | |
| Noro et al. | A two-gene prognostic classifier for early-stage lung squamous cell carcinoma in multiple large-scale and geographically diverse cohorts | |
| JP2016521979A5 (cg-RX-API-DMAC7.html) | ||
| Wan et al. | Diagnostic significance of circulating long noncoding RNA PCAT6 in patients with non-small cell lung cancer | |
| JP6611411B2 (ja) | 膵臓がんの検出キット及び検出方法 | |
| JP7633159B2 (ja) | メラノーマの転移及び患者の予後を予測するための遺伝子シグネチャー | |
| Zhao et al. | Diagnostic value of NKG2D promoter methylation in hepatitis B virus-associated hepatocellular carcinoma | |
| CN110760584A (zh) | 前列腺癌疾病进展生物标志物及其应用 | |
| AU2017282420A1 (en) | MMP1 gene transcript for use as marker for diagnosis of ovarian cancer prognosis, and test method | |
| WO2020032228A1 (ja) | 前立腺がんの検出のためのキット、デバイス及び方法 | |
| Lin et al. | Down-regulation of tissue microRNA-126 was associated with poor prognosis in patients with cutaneous melanoma | |
| CN111172285A (zh) | 用于胰腺癌早期诊断和/或预后监测的miRNA组及其应用 | |
| CN107858424B (zh) | miRNA-4731-3p作为原发性肺癌诊断标志物的应用 | |
| WO2020135422A1 (zh) | 健康风险评估方法 | |
| CN116959719A (zh) | 一种数据处理方法及非小细胞肺癌脑转移风险预测系统 |